Ref ID: 19267
Author:
Y. Mahabeer, C. C. Chang, D. Naidu, A. A. Dorasamy, S. Lewin, T. N’dungu, M-Y. S. Moosa, M. A. French, Y. Coovadia, K. P. Mlisana
Author address:
Univ. of Kwazulu-Natal, Durban, SOUTH AFRICA
Full conference title:
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy
Date: 10 September 2014
Abstract:
BACKGROUND: Amphotericin B and fluconazole form the backbone of cryptococcal meningitis (CM) treatment. Monitoring susceptibility to these and other antifungals is essential for the future management of the disease. Broth microdilution (BMD), the reference method, is labour-intensive therefore simpler yet equally reliable alternatives are needed. Etests and Vitek 2® are promising, commercially available alternatives however data of their performance for Cryptococcus neoformans is lacking. We aimed to compare the BMD results of Cryptococcus neoformans with those of Etests and Vitek 2 against amphotericin B, fluconazole, 5 flucytosine & voriconazole.
METHODS: Broth microdilution (BMD), Etests and Vitek 2 were conducted on 102 C.neoformans isolates from CSF of
patients at a tertiary hospital in Durban. BMD was
conducted according to the CLSI M27-A3 document. Etests
and Vitek 2® were carried out according to the
manufacturer’s recommendations. Essential agreements
(EA) were defined as results within 2 dilutions. CLSI
breakpoints (CLSI document M27-S4) were used to
determine categorical agreement (CA).
RESULTS: The EA of Etests for fluconazole and
voriconazole was 95 and 91% respectively but for
amphotericin B, it was 83%. The overall CA for Etests for
these drugs was 98%. For Vitek 2® , the overall EA and CA
for fluconazole, amphotericin B and 5 flucytosine was 96
and 97% respectively. There were 5 minor Etest
fluconazole results and 3 minor 5-flucytosine and
voriconazole errors each for Vitek 2® .
CONCLUSION: The Etests and Vitek 2® correlated very
well with BMD for fluconazole, 5-flucytosine and
voriconazole and these are suitable alternatives for the
susceptibility testing of Cryptococcus neoformans.
However, amphotericin B Etests were less reliable with MIC
values lower than BMD.
Abstract Number: NULL
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
C Gutierrez Perez1*, S Dhingra1,2, SM Kwansy3, TJ Opperman3, RA Cramer1
2022
93
-
v
PC Chatterjee1*, WC Chiu1, EBB Burgener2, PLB Bollyky3, JH Hsu1
2022
92
-
v
AS Serris1*, FU Uhel2, GMB Martin-Blondel3, OL Lambotte4, MEB Bougnoux5, EL Litvinova6, AO Ouedrani7, CR Rouzaud1, VB Bedarida8, JHR Raphalen9, FL Lanternier1,10
2022
91
-
v
ZA Lewis1, RB Meagher2*, S Ambati2, X Lin1
2022
90
-
v
QJ Choudhury1*, S Ambati2, X Lin1, ZA Lewis1, RB Meagher2
2022
-
v
M James1*, KW Liu1, E Vesley1, T Hohl2, RA Cramer1
2022
88
-
v
D Luptakova1, RH Patil1,2, V Havlicek1,2*
2022
87
-
v
EI Matthaiou1*, W Chiu1, C Conrad2, J Hsu1
2022
86
-
v
H Kamboj*, M Vijay, L Gupta, P Vijayaraghavan
2022
85
-
v
S Hartung1,2*, TNM Hoang1,2*, Z Cseresnyes3*, N Schuck1, K Rennert4,5, F Klos6, AS Mosig5,7, MT Figge3,8, M von Lilienfeld-Toal1,2
* Authors 1, 2 and 3 contributed equally
2022
84
